Neogen® Announces Two Senior Leadership Appointments

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Very Positive)

Key Terms

p&l financial

A P&L, short for profit and loss statement, is a snapshot of a company's money in and money out over a set period that shows whether the business made a profit or suffered a loss. Think of it like a household budget or a scorecard: it shows sales, costs and the bottom-line result, helping investors judge whether the company is earning enough, managing expenses, and likely to grow or face financial stress.

molecular diagnostics medical

Molecular diagnostics are laboratory tests that look for specific molecules — such as genes, pieces of DNA or RNA, or proteins — to detect disease, predict risk, or guide treatment choices. For investors, these tests matter because they can change how illnesses are diagnosed and treated, create recurring revenue through specialized tests and companion products, and face clear regulatory and reimbursement pathways that drive commercial value; think of them as reading a biological barcode to inform medical decisions.

point-of-care medical

"Point-of-care" refers to the location where immediate decision-making or actions happen, often involving the direct delivery of services or results. In healthcare, it describes tests or treatments performed directly at the patient's side, rather than in a distant laboratory. For investors, understanding "point-of-care" highlights the convenience, speed, and potential growth opportunities of services or products that bring solutions directly to the user or patient.

regulatory affairs regulatory

Regulatory affairs is the team and processes that secure and maintain government approvals, permits, and ongoing compliance for a company’s products, such as drugs, medical devices, or financial offerings. Think of them as the navigator and permit office that prepares submission paperwork, answers regulator questions, and monitors safety and labeling after launch. Their work matters to investors because regulatory timing, costs, and approval risk directly affect a product’s ability to reach markets and generate revenue.

01/05/2026 - 08:45 AM

LANSING, Mich.--(BUSINESS WIRE)-- Neogen Corporation (NASDAQ: NEOG) today announced the appointments of Joe Freels as Senior Vice President and Chief Commercial Officer, effective January 5, 2026, and Dr. Tammi Ranalli as Senior Vice President and General Manager, Global Food Safety, effective January 7, 2026.

As Senior Vice President and General Manager for Neogen’s Food Safety business unit, Dr. Ranalli will have full P&L responsibility for Neogen’s global Food Safety portfolio and will develop and execute the global strategy for continued innovation and growth, including marketing, research and development, and government and regulatory affairs. She joins Neogen from QuidelOrtho, where she served as Senior Vice President and General Manager for the company’s molecular diagnostics and point-of-care business units.

As Senior Vice President and Chief Commercial Officer, Mr. Freels will lead Neogen’s global Food Safety commercial strategy, including sales, customer and technical services, regional marketing, and global commercial excellence. He brings more than 20 years of experience across diagnostics, life sciences, and healthcare, most recently serving as Senior Vice President, Global Commercial Operations at Cepheid.

“Tammi and Joe are both exceptional leaders, and we are pleased to welcome them to Neogen,” said Mike Nassif, President and Chief Executive Officer of Neogen. “Their combined commercial, scientific, and operational expertise will be instrumental as we continue to strengthen our Food Safety business and support our customers around the world.”

About Neogen

Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.